Compound Profile

Caffeine

Reaction time; fatigue reduction; safety screen: anxiety disorder; uncontrolled hypertension; arrhythmia.

Last reviewed: •1 source citedReport a correctionProfile-wide ·B Moderate

Review needed — Safety evidence: adverse effects are dose and susceptibility dependent and include sleep disruption, anxiety like symptoms, and cardiovascular effects. Details

Evidence
Moderate evidence
Typical onset
Varies by prep
Safety rating
Review needed: Safety review pending
Best for
Adenosine A1 Receptor, Adenosine A2A Receptor, Epinephrine/Norepinephrine Signaling
Verdict: CaffeineYes

Bottom line

The most reliable cognitive enhancer available — the real questions are dose, timing, and tolerance. Pairing it with L-theanine smooths the jitters.
Evidence confidence
Strong — the best-evidenced cognitive stimulant there is
Expected onset
15–45 minutes
Give it
Immediate

Safety: Late or high doses wreck sleep and can amplify anxiety; taper rather than stack endlessly.

On the evidence: Extensive human evidence for alertness and performance.

Best for

  • Alertness and reaction time
  • Pushing through low-energy focus windows
  • Pre-workout drive

Not ideal for

  • Anxiety-prone users at higher doses
  • Late-day use if sleep matters
  • Calm, jitter-free focus alone
Permanent link to this scientific verdict
How strong is the evidence?Strong

Why not higher

  • Tolerance builds, so the benefit shrinks with habitual use
  • The effect is alertness, not deep cognition or learning

Why not lower

  • Large, consistent human evidence for alertness and reaction time
  • A well-understood mechanism and dose-response

Practical takeaway: The most reliable focus tool — manage dose and timing, keep it out of the late afternoon, and pair with L-theanine if it makes you jittery.

Next steps

Start here

New to this? Begin with L-theanine + caffeine for focus.

Compare first

Continue reading

Caffeine monograph visual
The Hippie Scientist

Safety

Safety & Cautions

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Stimulant-Like ProfileStimulant-like or activating caution language is present.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Safety evidence
adverse effects are dose- and susceptibility-dependent and include sleep disruption, anxiety-like symptoms, and cardiovascular effects
Who should avoid this?
No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
Talk to a professional if
you are pregnant or breastfeeding.

Pregnancy guidance uses lower intake thresholds; total intake from all sources and concurrent stimulants should be reviewed.

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

26 flagged pairings

Serotonergic activity

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Serotonergic activityCertainty: Theoretical

Data provenance recorded for 26 of 26 pairings in this mechanism group.

+14 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Moderate Caution

81 flagged pairings

Blood-pressure effects

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Blood-pressure effectsCertainty: Theoretical

Data provenance recorded for 81 of 81 pairings in this mechanism group.

+69 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence Summary

Profile-wide ·B Moderate

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateModerate evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Neurotransmitter Modulation · Vascular Function Support · Hormonal Signaling Context

Research maturity: Established research — main contexts: Adenosine A1 Receptor · Adenosine A2A Receptor · Epinephrine/Norepinephrine Signaling

Safety boundary: Safety note available — Safety evidence: adverse effects are dose and susceptibility dependent and include sleep disruption, anxiety like symptoms, and cardiovascular effects.

This profile cites 1 human study.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Moderate evidence

Caffeine has a moderate evidence rating.

AdaptogenStress & Mood
Citation density
1.2
Sources
7
Effects
6
Research recency
Mixed recency
Evidence Grade

Grade B: Moderate Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta analysis
Risk of Bias
Low
Consistency
Consistent
Strongest recorded design is a meta analysis, drawn from 8 recorded studies, 7 in people. No disagreement is recorded across them.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (7)5 human evidence sources · 1 human trial · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 7 of 7 studies.

What the evidence actually shows

This table contains 7 structured sources, including 5 human evidence sources; 1 is a human trial.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

A 2026 meta-analysis of randomized athlete studies found higher odds of headache, abdominal discomfort, tachycardia, insomnia, increased urination, anxiety, and nervousness after acute caffeine versus placebo, with several side effects increasing as studied caffeine exposure increased.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————A 2026 meta-analysis of randomized athlete studies found higher odds of headache, abdominal discomfort, tachycardia, insomnia, increased urination, anxiety, and nervousness after acute caffeine versus placebo, with several side effects increasing as studied caffeine exposure increased.PubMed →

A meta-analysis of randomized studies found caffeine acutely increased intraocular pressure in healthy and glaucomatous populations, with significant increases at several time points.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————A meta-analysis of randomized studies found caffeine acutely increased intraocular pressure in healthy and glaucomatous populations, with significant increases at several time points.PubMed →

A 2024 meta-analysis found higher anxiety after caffeine exposure overall, with substantially larger effects in studies using more than 400 mg. The study designs and populations were heterogeneous.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————A 2024 meta-analysis found higher anxiety after caffeine exposure overall, with substantially larger effects in studies using more than 400 mg. The study designs and populations were heterogeneous.PubMed →

A systematic review and meta-analysis found that caffeine improved multiple attention, executive, reaction-time, information-processing, driving, and occupational-performance measures after sleep loss or restriction.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————A systematic review and meta-analysis found that caffeine improved multiple attention, executive, reaction-time, information-processing, driving, and occupational-performance measures after sleep loss or restriction.PubMed →

A randomized crossover trial found 3 mg/kg caffeine did not improve strength, power, or muscular-endurance outcomes, and habitual use did not modify the null effect.

Background
Randomized controlled trial

Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.

—————A randomized crossover trial found 3 mg/kg caffeine did not improve strength, power, or muscular-endurance outcomes, and habitual use did not modify the null effect.PubMed →

Is caffeine a cognitive enhancer?

PubMed · J Alzheimers Dis · 2010

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →
Show 1 more study

An ACOG committee opinion states that moderate caffeine consumption below 200 mg per day does not appear to be a major contributor to miscarriage or preterm birth, while evidence regarding fetal growth restriction remained uncertain.

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

—————An ACOG committee opinion states that moderate caffeine consumption below 200 mg per day does not appear to be a major contributor to miscarriage or preterm birth, while evidence regarding fetal growth restriction remained uncertain.PubMed →

How Caffeine Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Caffeine Works

How Caffeine WorksCaffeine acts on biological target pathways via neurotransmitter (modulation), leading to adenosine a1 receptor.CaffeineBiological TargetBiological pathwayNeurotransmitterModulationAdenosine A1 ReceptorObservable outcomeVascular FunctionSupport
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
capsule or standardized extract
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Neurotransmitter Modulation
  • Vascular Function Support
  • Hormonal Signaling Context
  • Stress Response Modulation
  • Neuroprotective Activity

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Sourcing options

Caffeine product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Caffeine, verify the label for:

  • Standardized Extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
  • Third-Party Testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
  • Form Bioavailability: Ensure the form matches evidence-supported configurations (e.g. chelated bisglycinate/glycinate for magnesium, micronized monohydrate for creatine) for optimal onset and digestion tolerance.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

By Willie B. Randolph III

Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Caffeine evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to compounds librarySafety checker →